This is the authors' abstract. We don't add key points for this paper.
Because of their moderate penetration power, β-rays (high-energy electrons) are a useful signal for evaluating the surface contamination of nuclear radiation. However, the development of β-ray scintillators, which convert the absorbed high-energy electrons into visible photons, is hindered by the limitations of materials selection. Herein, we report two highly luminescent zero-dimensional (0D) organic—inorganic lead-free metal halide hybrids, (C 13 H 30 N) 2 MnBr 4 and (C 19 H 34 N) 2 MnBr 4 , as scintillators exhibiting efficient β-ray scintillation. These hybrid scintillators combine the superior properties of organic and inorganic components. For example, organic components that contain light elements C, H, and N enhance the capturing efficiency of β particles; isolated inorganic [MnBr 4 ] 2− tetrahedrons serve as highly localized emitting centers to emit intense radioluminescence (RL) under β-ray excitation. Both hybrids show a narrow-band green emission peaked at 518 nm with photoluminescence quantum efficiencies (PLQEs) of 81.3% for (C 13 H 30 N) 2 MnBr 4 and 86.4% for (C 19 H 34 N) 2 MnBr 4 , respectively. To enable the solution processing of this promising metal halide hybrid, we successfully synthesized (C 13 H 30 N) 2 MnBr 4 colloidal nanocrystals for the first time. Being excited by β-rays, (C 13 H 30 N) 2 MnBr 4 scintillators show a linear response to β-ray dose rate over a broad range from 400 to 2,800 Gy·s −1 , and also display robust radiation resistance that 80% of the initial RL intensity can be maintained after an ultrahigh accumulated radiation dose of 240 kGy. This work will open up a new route for the development of β-ray scintillators.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Lian et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: